CFTR and cystic fibrosis: In addition, the possibility of developing compounds that activate alternative Cl- and K+ channels to compensate for the loss of CFTR activity is promising according to studies in both HEK 293 cells and IB3-1 cells, which were isolated from a CF patient expressing the ΔF508 mutation.